LANDAUER is a prominent name in the biotechnology and healthcare industries, offering innovative solutions to help organizations achieve their radiation safety goals. Established in 1954, the company has consistently been at the forefront of addressing radiation risks and developing monitoring standards and technologies for over 70 years. Their commitment to understanding and addressing common challenges in safety, compliance, and information management has positioned them as a trusted partner for thousands of companies. Through a focus on risk mitigation and the development of occupational and public health and safety regulations, LANDAUER aims to guide best practices in the industry. Notably, LANDAUER was acquired by Fortive in 2017 and is now a part of Fluke Health Solutions, showcasing its value and potential for further growth within the larger corporate structure. With a strong foundation and a focus on innovation, the company continues to pave the way for radiation safety and compliance. In summary, LANDAUER's position in the radiation safety sector, combined with its association with Fortive and Fluke Health Solutions, makes it a compelling investment opportunity for venture capitalists looking to tap into the biotechnology and healthcare industries.
There is no investment information
No recent news or press coverage available for LANDAUER.